1. Home
  2. SANM vs CYTK Comparison

SANM vs CYTK Comparison

Compare SANM & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanmina Corporation

SANM

Sanmina Corporation

HOLD

Current Price

$154.25

Market Cap

7.1B

Sector

Technology

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$66.30

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SANM
CYTK
Founded
1980
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
7.6B
IPO Year
1994
2004

Fundamental Metrics

Financial Performance
Metric
SANM
CYTK
Price
$154.25
$66.30
Analyst Decision
Buy
Strong Buy
Analyst Count
3
19
Target Price
$155.00
$89.26
AVG Volume (30 Days)
511.0K
1.7M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
14.07
N/A
EPS
0.89
N/A
Revenue
$7,890,475,000.00
$13,368,000.00
Revenue This Year
$75.52
$6.88
Revenue Next Year
$13.59
$308.26
P/E Ratio
$171.38
N/A
Revenue Growth
16.78
N/A
52 Week Low
$71.84
$29.31
52 Week High
$185.29
$70.98

Technical Indicators

Market Signals
Indicator
SANM
CYTK
Relative Strength Index (RSI) 66.98 58.00
Support Level $140.94 $59.12
Resistance Level $163.34 $69.48
Average True Range (ATR) 5.79 2.30
MACD 3.49 0.30
Stochastic Oscillator 93.66 73.74

Price Performance

Historical Comparison
SANM
CYTK

About SANM Sanmina Corporation

Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense, and aerospace end markets. The operations are managed as two businesses: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue mainly in the United States, China, and Mexico, but has a presence around the world.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: